Northern Trust Corp Bio Affinity Technologies, Inc. Transaction History
Northern Trust Corp
- $600 Billion
- Q3 2024
A detailed history of Northern Trust Corp transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 13,662 shares of BIAF stock, worth $12,978. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,662
Previous 13,662
-0.0%
Holding current value
$12,978
Previous $29,000
3.45%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BIAF
# of Institutions
15Shares Held
468KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA261KShares$247,8250.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.2KShares$82,8210.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$26,4900.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC20KShares$19,0000.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$16,7200.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $2.59M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...